Follicle Centre Lymphoma: Treatment Results for Stage I and II;Behandlungsergebnisse beim follikulären Keimzentrumslymphom Stadium I und II

Strahlentherapie und Onkologie

Volumn 179, Issue 12, 2003, Pages 840-846

  Neumann, Holger ^a   Blanck, Hilpert ^b   Koch, Rainer ^b   Fiedler, Steffen ^b   Lesche, Aquina ^b   Herrmann, Thomas ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

CC CB Lymphoma; Follicle centre lymphoma; Radiotherapy; Relapse pattern

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HUMAN; LYMPH NODE; LYMPHANGIOGRAPHY; LYMPHOMA; MAJOR CLINICAL STUDY; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LYMPHOGRAPHY; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PARTICLE ACCELERATORS; PREDNISONE; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0345530019     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1025-0     Document Type: Article

References (41)

1. Allen IE, Ross SD, Borden SP, et al. Meta-analysis to assess the efficacy of interferon-alpha in patients with follicular non-Hodgkin's lymphoma. J Immunther 2001;24:58-65.
2. Battmann A, Diekmann K, Battmann A, et al. Mediastinal Hodgkin's lymphomas in computerized tomography. Comparison of exact CT-assisted volumetry and volume assessment using simple geometric models. Strahlenther Onkol 2001;177:132-7.
3. Brandt L, Nygren P, Glimelius B, et al. A systemic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma. Acta Oncol 2001;40:213-23.
4. Buckstein RJ, Rimrie K, Pennell N, et al. Prolonged molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab. Leuk Lymphoma 2001;41:451-5.
5. Carde P, Burgers JM, Van Glabbeke M, et al. Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol 1984;2:301-2.
6. Clouse ME, Harrison DA, Grassi CJ, et al. Lymphangiography and computed tomography in Hodgkin's disease and non-Hodgkin's lymphoma. J Comput Tomogr 1985;9:1-8.
7. Coiffier B, Bastion F, Berger P. Prognostic factors in follicular lymphomas. Seminars in Oncology 1993;5:89-95.
8. Colombat P, Salles G, Brousse N, et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden. Clinical and molecular evaluation. Blood 2001; 97:101-6.
9. Denham JW, Denham E, Dear KB, et al. The follicular non-Hodgkin's lymphomas - the possibility of cure. Eur J Cancer 1996;32A:470-9.
10. Feuerbach S, Reiser M, Fink U, et al. [Possibilities and limitations of computerized tomography in the staging of the subdiaphragmal spread of Hodgkin's disease]. Dtsch Med Wochenschrift 1985;110:288-92.
11. Fisher RI. Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma. Semin Oncol 2000;27(Suppl 12):2-8.
12. Frank C, Zierhut D, Schulz-Ertner D, et al. Centroblastic-Centrocytic Non-Hodgkin's Lymphoma Stage I-II: Patterns of Failure Following Radiotherapy. Strahlenther Onkol 2001;11:597-603.
13. Gospodarowicz MK, Bush, RS, Brown TC. Prognostic factors in nodular lymphomas: A multivariate analysis based on the prince margret Hospital experience. Int J Radiat Oncol Biol Phys 1984;10:489-97.
14. Hiddemann W, Longo DL, Coiffier B, et al. Lymphoma classification - the gap between biology and clinical management is closing. Blood 1996;88: 4085-9.
15. Hiddemann W, Dreyling M, Unterhalt M. Aktuelle Entwicklungen in der Therapie follikulärer Keimzentrumslymphome. Onkologe 2001;7:969-81.
16. Horning SJ. Follicular lymphoma: we made any progress? Ann Oncol 2000;11:23-7.
17. Kamath SS, Marcus RB, Lynch JW; et al: The impact of radiotherapy dose and other treatment-releated and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma. Int J Radiation Oncol Biol Phys 1999;44:563-8.
18. Lawrence T, Urba W, Steinberg S, et al. Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute. Int J Radiat Oncol Biol Phys 1988;14:417-24.
19. MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at stanford university. J Clin Oncol 1996;14:1282-90.
20. McLaughlin P, Fuller L, Velasquez W et al. Stage I-II Follicular Lymphoma. Cancer 1986;58:1596-602.
21. Monfardini S, Banfi A, Bonadonna G, et al. Improved five year survival after combined radiotherapy - chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1980;6:125-34.
22. Murtha AD, Knox SJ, Rupnow BA, et al. Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Int J Radiat Oncol Biol Phys 2001;49:1-2.
23. Nawaratne S, Fabiny R, Brien JE, et al. Accuracy of volume measurement using heliacal CT. J Comput Assist Tomogr 1997;21:481-6.
24. Nissen NI, Ersboll J, Hansen HS, et al. A randomized study of radiotherapy plus chemotherapy in stage I-II non-Hodgkin' lymphomas. Cancer 1983; 52:1-7.
25. Oh YK, Ha CS, Samuels BI, et al. Stage I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies. Radiology 1999;210: 483-6.
26. Paryani S, Hoppe Cox R, et al. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies stage I and II. Cancer 1983;52:2300-7.
27. Pendlebury S, El Awadi M, Ashley S, et al. Radiotherapy results in early stage low grade non-Hodgkin's lymphoma. Radiother Oncol 1995;36: 167-71.
28. Rohatiner A, Radford J, Deakin D, et al. A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma. Br J Cancer 2001;85:29-35.
29. Sack H, Hoederath M, Stuschke M. et al. Strahlenbehandlung von follikulären Keimzentrumslymphomen. Strahlenther Onkol 1998;174:78-85.
30. Sack H, Engelhardt M. Therapie der niedrigmalignen nodalen Non-Hodgkin-Lymphome in frühen Stadien mit alleiniger Radiotherapie. Essen: Studienprotokoll, März 1998.
31. Schmidberger H, Hess CF, Rübe Ch. Stellenwert der Strahlentherapie bei nodalen Non-Hodgkin-Lymphomen in lokalen und fortgeschrittenen Stadien. Onkologe 2001;7:960-8.
32. Shiels RA, Stone J, Ash DV, et al. Priorities for computed tomography and lymphography in the staging and initial management of Hodgkin's disease. Clin Radiol 1994;35:477-9.
33. Soubeyran P, Debled M, Tehen N, et al. Follicular lymphomas - a review of treatment modalities. Crit Rev Oncol Hematol 2000;35:13-32.
34. Stuschke M, Hoederath A, Sack H, et al. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic non-Hodgkin's Lymphoma. Cancer 1997;15:2273-84.
35. Taylor RE, Allan SG, McIntyre MA, et al. Low grade stage I and II Non-Hodgkin's Lymphoma: Results of treatment and relapse pattern following radiotherapy. Clinical Radiology 1988;39:3909-18.
36. Tiemann M, Trümper L. Pathologie, Biologie und Klassifikation maligner Non-Hodgkin-Lymphome. Onkologe 2001;7:940-59.
37. The Non-Hodgkin's Lymphoma Classification Project. A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. Blood 1997;89:3909-18.
38. Vaughan Hudson B, Vaughan Hudson G, MacLennan KA. Clinical stage I non-Hodgkin's lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994;69:1088-93.
39. Weisenberger DD. Epidemiology of non-Hodgkin's lymphoma: recent findings regarding and emerging epidemic. Ann Oncol 1994;Suppl.1:19-24.
40. Williams RG, Koehler PR. Normal anatomy and limitations in CT interpretation of lymph node disease. J Comput Tomogr 1979;3:190-6.
41. Yahalom J, Varsos G, Fuks Z, et al. Adjuvant cyclophasphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin's lymphoma. Cancer 1993;71:2342-50.